News Pfizer axes Alzheimer's and Parkinson's research Big pharma will continue developing tanezumab painkiller with Lilly
News Acorda axes Parkinson's drug after trial deaths Biotech not confident white blood cell counts could ensure patient safety.
Partner Content Partner Content 2018 Agenda Released: World CNS Summit Targeting Neurodegenerative Diseases
News Allergan negotiates option to buy neurology biotech Allergan to co-develop Parkinson's drug with Lysosomal Therapeutics
News Verily’s ‘smart spoon’ combats Parkinson’s tremors Device allows those with neurodegenerative disorders to eat without spilling their food.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
